T
Healthcare and Life Sciences
Tausif Qudsi
Answer 1
Views 459
0

PD-1/PDL-1 Inhibitor Market

What is the average total number or percentage of metastatic cervical cancer patients whose tumors express PD-L1 (CPS ?1)?

Oncology

immunoncology

Therapeutics

cancer